Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 279.00
+6.70 (2.46%)
Nov 4, 2026, 5:29 PM CET
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 75.99 billion as of November 4, 2026. It is the 2,611th most valuable company in the world and the 38th biggest in Sweden. Its market cap has increased by 25.56% in one year.
Market Cap
75.99B
Enterprise Value
84.13B
Revenue
34.46B
Global Rank
Country Rank
#38 Sweden
PE Ratio
26.85
ChartMarket Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 75.99B, an increase of 399.41%. That is a compound annual growth rate of 5.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 75.99B | 27.51% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 64.81B |
| Elekta AB | 23.74B |
| Vitrolife AB | 15.37B |
| Nolato AB | 14.01B |
| MedCap AB | 8.30B |
| Xvivo Perfusion AB | 6.33B |
| CellaVision AB | 4.67B |
| BICO Group AB | 1.71B |